Preview Mode Links will not work in preview mode

MPR Weekly Dose

MPR Weekly Dose #62 - Major vaccine developments; FDA authorizes rapid at-home COVID test; New findings for glucosamine supplementation; And a novel budesonide oral suspension gets Priority Review

Dec 18, 2020

Its been a long year, but the monumental efforts to achieve a COVID-19 vaccine are bearing some fruits, we about that, and also a fully at home diagnostic COVID test, as well as new findings related to glucosamine supplements and a novel treatment for eosinophilic esophagitis.

MPR Weekly Dose #61 - Sitagliptin findings in pediatrics; Obesity treatment gains expanded approval; The FDA issue a CRL; And a new transdermal contraceptive

Dec 11, 2020

This week we cover new findings for the diabetes drug sitagliptin in pediatrics; An obesity treatment has approval expanded; The FDA issue a Complete Response Letter for an outpatient alternative treatment; And news of availability for a transdermal contraceptive patch.

MPR Weekly Dose #60 - The FDA stand by remdesivir; Who should get the vaccine first? Xolair and Hetlioz gain expanded approvals; And a novel neuroblastoma treatment

Dec 4, 2020

This week we cover a back and forth between the FDA and the WHO over remdesivir efficacy; Recommendations for who should get a COVID vaccine first; Xolair and Hetlioz have approval expansions; And a novel neuroblastoma treatment gets accelerated approval. Moreover, there's movie trivia!